We used thalidomide to treat 10 patients with advanced stage multiple myeloma who had failed to obtain at least a partial response after a VAD-based induction therapy. Seven out 10 cases achieved clinical and histologic responses and proceeded to collection of peripheral blood stem cells and transplantation and ASCT.
Thalidomide before autologous stem cell transplantation in VAD-refractory multiple myeloma patients
PATRIARCA, Francesca;ZAJA, Francesco;FANIN, Renato
2003-01-01
Abstract
We used thalidomide to treat 10 patients with advanced stage multiple myeloma who had failed to obtain at least a partial response after a VAD-based induction therapy. Seven out 10 cases achieved clinical and histologic responses and proceeded to collection of peripheral blood stem cells and transplantation and ASCT.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Patriarca Haematologica 2003.pdf
non disponibili
Tipologia:
Altro materiale allegato
Licenza:
Non pubblico
Dimensione
131.31 kB
Formato
Adobe PDF
|
131.31 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
